Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Mesothelioma, Malignant 2Colorectal Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Liposarcoma, Myxoid 1Kidney Neoplasms 1Infections 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Voriconazole 2Caspofungin 2telavancin 1monalizumab 1fludarabine phosphate 1fish oil triglycerides 1avdoralimab 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Therapeutics 1Tacrolimus 1Standard of Care 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Observation 1Methotrexate 1Melphalan 1Interferon-gamma 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Daptomycin 1Cyclophosphamide 1Clarithromycin 1Bevacizumab 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Infections × Interferon-gamma × Clear all
NCT00059878 2013-06-19

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

National Cancer Institute (NCI)

Phase 2 Completed

Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡